MDCX · Medicus Pharma Ltd
United States · RS rating 2 · As of 2026-10-14
| Price | 3.12 USD |
|---|---|
| 1-day change | -4.9% |
| RS rating (overall / 1M / 3M / 12M) | 2 / 2 / 2 / 2 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 15 / 30 |
| Industry group (rank) | Medical-Ethical Drugs (91) |
| EPS growth Q/Q | +32.3% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +97.7% |
| Market cap (USD) | $13.1M |